AMBEV S.A. — Director's Dealing 2026

May 8, 2026

6-K 1 abevcvm358apr26_6k1.htm 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of May, 2026

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F X Form 40-F _

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _ No X_

Field: Page; Sequence: 1

Field: /Page

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From April 1 st to 30 th , 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1) :

Company Name: Ambev S.A. — Group and Related Persons	( X ) Board of Directors	( ) Management	( ) Fiscal Council			( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				30,699,742
ADR		Common				468,040
Transactions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day	Quantity	Price	Volume (R$) (3)
Shares	Common	N/A	Renounce	30	20,115	0.00	0.00
Final Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				30,679,627
ADR		Common				468,040

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

Field: Page; Sequence: 2

Field: /Page

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From April 1 st to 30 th , 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1) :

Company Name: Ambev S.A. — Group and Related Persons	( ) Board of Directors	( X ) Management		( ) Fiscal Council		( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				4,753,962
ADR		Common				19,790
Transactions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day	Quantity	Price	Volume (R$) (3)
Final Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				4,753,962
ADR		Common				19,790

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

Field: Page; Sequence: 3

Field: /Page

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 44/2021

From April 1 st to 30 th , 2026 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021 (1) :

Company Name: Ambev S.A. — Group and Related Persons	( ) Board of Directors	( ) Management	( X ) Fiscal Council		( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				2,500
Transactions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day	Quantity	Price	Volume (R$) (3)
Shares	Common	N/A	Renounce	30	0	0.00	0.00
Final Balance
Securities / Derivatives		Securities Characteristics (2)				Quantity
Shares		Common				2,500

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Field: Page; Sequence: 4

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 8, 2026

AMBEV S.A.
By:	/s/ Guilherme Fleury de Figueiredo Ferraz Parolari
	Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer